Dystroglycanopathies are a subset of muscular dystrophies due to reduced O-glycosylation in α-dystroglycan with diminished laminin-binding activity. Here, LAMB2 is linked to neuromuscular disease caused by qualitative or quantitative defects of alpha-dystroglycan.